Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 10, 2022

SELL
$126.25 - $231.85 $221,442 - $406,664
-1,754 Closed
0 $0
Q4 2021

Feb 07, 2022

SELL
$216.64 - $362.52 $28,163 - $47,127
-130 Reduced 6.9%
1,754 $452,000
Q3 2021

Nov 10, 2021

SELL
$205.93 - $447.23 $188,425 - $409,215
-915 Reduced 32.69%
1,884 $514,000
Q2 2021

Aug 04, 2021

BUY
$113.32 - $241.49 $72,978 - $155,519
644 Added 29.88%
2,799 $627,000
Q1 2021

May 10, 2021

BUY
$85.73 - $119.5 $184,748 - $257,522
2,155 New
2,155 $235,000

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $27.7B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Wrapmanager Inc Portfolio

Follow Wrapmanager Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wrapmanager Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wrapmanager Inc with notifications on news.